Skip to Main Content
Boston University
  • Bostonia
  • BU Today
  • The Brink
  • University Publications

    • Bostonia
    • BU Today
    • The Brink
  • School & College Publications

    • The Record
Other Publications
BU Today
  • Sections
News, Opinion, Community

Boosting Biosurveillance

BU prof hopes to build a better system to detect disease outbreaks

September 12, 2006
  • John Thompson
Twitter Facebook
Alexander Ozonoff, SPH professor of biostatistics and Paola Sebastiani, SPH associate professor of biostatistics.

Information can be the most powerful weapon to combat a bioterrorist attack or pandemic influenza. To this end, the Centers for Disease Control and Prevention (CDC) has developed a nationwide biosurveillance system, BioSense, to provide early warnings and real-time information on disease outbreaks. Helping to improve the warning system is Alexander Ozonoff, a School of Public Health assistant professor of biostatistics, who along with co-investigator Paola Sebastiani, an SPH associate professor of biostatistics, received a $700,000 grant from the CDC. Ozonoff discussed the project with BU Today.

BU Today: What aspects of BioSense need improving?
Ozonoff: BioSense is a really ambitious project for CDC. Right now the program is working to invite more hospitals across the country to participate, which will expand coverage. The real problem that we, and other groups, are trying to address is what to do with all the data that are collected. The belief is that the signal of an important public health event, whether a bioterror attack or a massive outbreak of infectious disease, will be present in the BioSense data, but detecting that signal is a challenging statistical problem. Funding for this research project, and others like it, is meant to address that problem. 

How early can you catch an event?
It’s not clear how early we can catch an event. The goal is always to improve timeliness (how early) along with sensitivity (don’t miss any events) and specificity (low false-alarm rate). We hope that improved statistical methods can improve on all three of these operating characteristics. In general, it’s hard to say how much early warning we can provide since each outbreak is very different.  

Who decides on the standards for identifying threats, and what happens after a threat has been identified?

Determining what constitutes a threat to the public health is fundamental to BioSense, and to public health surveillance in general. There are two issues to deal with: first, if we see an increase in disease, or a geographic cluster of disease, is this increase due to chance (random variability in the number of people who are sick at any one time) or is it a signal of something important happening? This is where statistics play an important role. If we can say with some degree of confidence that the increase is not likely to be due to chance, then we must determine if it is important enough to act upon. These decisions are generally made by public health officials working together with statisticians and epidemiologists who are familiar with the surveillance system. So the decision-making process is intrinsically tied together with the collection, analysis, and interpretation of the data coming in. Each potential outbreak is generally considered on a case-by-base basis by public health officials at the local, state, or national level.

How does information get into the system, and what will it take to make this a nationwide network?
The BioSense infrastructure allows for data from multiple locations to be transmitted electronically to CDC, where the data can be analyzed centrally. Hospitals that agree to participate must meet the technical specifications determined by CDC in order to guarantee uninterrupted, consistent data flow. Right now, nationwide data from Department of Defense and the VA hospital system are part of the BioSense system, so in that sense it is already nationwide. As more hospitals from outside those two health-care systems are added, BioSense will continue to grow and expand its coverage to include more and more of the United States.

Explore Related Topics:

  • Faculty
  • Research
  • Share this story

Share

Boosting Biosurveillance

Share

  • Twitter
  • Facebook
  • Reddit
  • LinkedIn
  • Email
  • John Thompson

    John Thompson Profile

Latest from BU Today

  • Rowing

    BU Rowing Teams Prepare for IRA National Championship Regatta

  • Things-to-do

    To Do Today: Beacon Hill Art Walk

  • In the City

    Getting to Know Your Neighborhood: Davis Square

  • Things-to-do

    To Do Today: The Light in the Piazza

  • Jobs

    Job-Hunting as a New Graduate: What You Need to Know

  • Education

    What’s Behind the Rise in Violence Against Teachers?

  • Fine Arts

    How I Made This: Jacob Whitchurch (CFA’26)

  • Things-to-do

    To Do Today: Seaport Sweat

  • Film & TV

    Did You Win Free Tickets to See Mission: Impossible—The Final Reckoning Tonight?

  • COMMENCEMENT 2025

    Experience BU’s 2025 Commencement from a Terrier Point of View

  • Obituaries

    Remembering Leslie Epstein, Pillar of BU’s Creative Writing Program

  • Voices & Opinion

    POV: This Memorial Day, Remember BU’s Fallen Heroes by Visiting the New Online Honor Wall

  • University News

    23 Charles River Campus Faculty Promoted to Full Professor

  • Commencement 2025

    Photos: A Look Back at BU’s Commencement

  • Theatre

    It’s “Prom Season” at Wheelock Family Theatre

  • Things-to-do

    Six Spots to Check Out This Memorial Day in Boston

  • Commencement 2025

    Video: Class of 2025: What We’ll Take with Us as We Begin a New Chapter

  • Health & Medicine

    What Does Biden’s Cancer Diagnosis Mean?

  • Watch Now

    BU’s Class of 2025: What Are Your Plans After Graduating?

  • Fitness

    BU Sports Rehab Therapists on Jayson Tatum’s Achilles Injury and Recovery Ahead

Section navigation

  • Sections
  • Must Reads
  • Videos
  • Series
  • Close-ups
  • Archives
  • About + Contact
Get Our Email

Explore Our Publications

Bostonia

Boston University’s Alumni Magazine

BU Today

News, Opinion, Community

The Brink

Pioneering Research from Boston University

  • Twitter
  • Facebook
  • Youtube
  • LinkedIn
  • Instagram
  • Weibo
  • TikTok
© Boston University. All rights reserved. www.bu.edu
© 2025 Trustees of Boston UniversityPrivacy StatementAccessibility
Boston University
Notice of Non-Discrimination: Boston University prohibits discrimination and harassment on the basis of race, color, natural or protective hairstyle, religion, sex or gender, age, national origin, ethnicity, shared ancestry and ethnic characteristics, physical or mental disability, sexual orientation, gender identity and/or expression, genetic information, pregnancy or pregnancy-related condition, military service, marital, parental, veteran status, or any other legally protected status in any and all educational programs or activities operated by Boston University. Retaliation is also prohibited. Please refer questions or concerns about Title IX, discrimination based on any other status protected by law or BU policy, or retaliation to Boston University’s Executive Director of Equal Opportunity/Title IX Coordinator, at titleix@bu.edu or (617) 358-1796. Read Boston University’s full Notice of Nondiscrimination.
Search
Boston University Masterplate
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Boosting Biosurveillance
0
share this